100 related articles for article (PubMed ID: 27887848)
1. Simvastatin inhibits tumor angiogenesis in HER2-overexpressing human colorectal cancer.
Li G; Zheng J; Xu B; Ling J; Qiu W; Wang Y
Biomed Pharmacother; 2017 Jan; 85():418-424. PubMed ID: 27887848
[TBL] [Abstract][Full Text] [Related]
2. Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis.
Wang J; Li G; Wang Y; Tang S; Sun X; Feng X; Li Y; Bao G; Li P; Mao X; Wang M; Liu P
Oncotarget; 2015 Dec; 6(42):44579-92. PubMed ID: 26625311
[TBL] [Abstract][Full Text] [Related]
3. Continuous administration of bevacizumab plus capecitabine, even after acquired resistance to bevacizumab, restored anti-angiogenic and antitumor effect in a human colorectal cancer xenograft model.
Iwai T; Sugimoto M; Harada S; Yorozu K; Kurasawa M; Yamamoto K
Oncol Rep; 2016 Aug; 36(2):626-32. PubMed ID: 27350037
[TBL] [Abstract][Full Text] [Related]
4. Squalamine blocks tumor-associated angiogenesis and growth of human breast cancer cells with or without HER-2/neu overexpression.
Márquez-Garbán DC; Gorrín-Rivas M; Chen HW; Sterling C; Elashoff D; Hamilton N; Pietras RJ
Cancer Lett; 2019 May; 449():66-75. PubMed ID: 30771431
[TBL] [Abstract][Full Text] [Related]
5. The role of HER2 in angiogenesis.
Kumar R; Yarmand-Bagheri R
Semin Oncol; 2001 Oct; 28(5 Suppl 16):27-32. PubMed ID: 11706393
[TBL] [Abstract][Full Text] [Related]
6. Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells.
Chuang TC; Hsu SC; Cheng YT; Shao WS; Wu K; Fang GS; Ou CC; Wang V
Cancer Lett; 2011 Dec; 311(1):11-9. PubMed ID: 21757288
[TBL] [Abstract][Full Text] [Related]
7. Bevacizumab terminates homeobox B9-induced tumor proliferation by silencing microenvironmental communication.
Hoshino Y; Hayashida T; Hirata A; Takahashi H; Chiba N; Ohmura M; Wakui M; Jinno H; Hasegawa H; Maheswaran S; Suematsu M; Kitagawa Y
Mol Cancer; 2014 May; 13():102. PubMed ID: 24885802
[TBL] [Abstract][Full Text] [Related]
8. FOXF1 promotes angiogenesis and accelerates bevacizumab resistance in colorectal cancer by transcriptionally activating VEGFA.
Wang S; Xiao Z; Hong Z; Jiao H; Zhu S; Zhao Y; Bi J; Qiu J; Zhang D; Yan J; Zhang L; Huang C; Li T; Liang L; Liao W; Ye Y; Ding Y
Cancer Lett; 2018 Dec; 439():78-90. PubMed ID: 30253191
[TBL] [Abstract][Full Text] [Related]
9. SV40 T/t-common polypeptide inhibits angiogenesis and growth of HER2-overexpressing human ovarian cancer.
Hsueh SP; Hsu WB; Wen CC; Wang WB
Cancer Gene Ther; 2011 Dec; 18(12):859-70. PubMed ID: 21869825
[TBL] [Abstract][Full Text] [Related]
10. Analysis of PTEN, VEGF, HER2 and P53 status in determining colorectal cancer benefit from bevacizumab therapy.
Kara O; Duman BB; Kara B; Erdogan S; Parsak CK; Sakman G
Asian Pac J Cancer Prev; 2012; 13(12):6397-401. PubMed ID: 23464465
[TBL] [Abstract][Full Text] [Related]
11. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression.
Laughner E; Taghavi P; Chiles K; Mahon PC; Semenza GL
Mol Cell Biol; 2001 Jun; 21(12):3995-4004. PubMed ID: 11359907
[TBL] [Abstract][Full Text] [Related]
12. Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis.
Yen L; You XL; Al Moustafa AE; Batist G; Hynes NE; Mader S; Meloche S; Alaoui-Jamali MA
Oncogene; 2000 Jul; 19(31):3460-9. PubMed ID: 10918604
[TBL] [Abstract][Full Text] [Related]
13. Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma.
Patterson DM; Gao D; Trahan DN; Johnson BA; Ludwig A; Barbieri E; Chen Z; Diaz-Miron J; Vassilev L; Shohet JM; Kim ES
Angiogenesis; 2011 Sep; 14(3):255-66. PubMed ID: 21484514
[TBL] [Abstract][Full Text] [Related]
14. Guggulsterone inhibits angiogenesis by blocking STAT3 and VEGF expression in colon cancer cells.
Kim ES; Hong SY; Lee HK; Kim SW; An MJ; Kim TI; Lee KR; Kim WH; Cheon JH
Oncol Rep; 2008 Dec; 20(6):1321-7. PubMed ID: 19020709
[TBL] [Abstract][Full Text] [Related]
15. Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90α in human colorectal cancer.
Lee SJ; Lee I; Lee J; Park C; Kang WK
Br J Cancer; 2014 Jul; 111(3):497-505. PubMed ID: 24945998
[TBL] [Abstract][Full Text] [Related]
16. Patrinia scabiosaefolia inhibits colorectal cancer growth through suppression of tumor angiogenesis.
Chen L; Liu L; Ye L; Shen A; Chen Y; Sferra TJ; Peng J
Oncol Rep; 2013 Sep; 30(3):1439-43. PubMed ID: 23820929
[TBL] [Abstract][Full Text] [Related]
17. Jiedu Xiaozheng Yin, a Chinese herbal formula, inhibits tumor angiogenesis via downregulation of VEGF-A and VEGFR-2 expression in vivo and in vitro.
Cao Z; Lin W; Huang Z; Chen X; Zhao J; Zheng L; Ye H; Liu Z; Liao L; Du J
Oncol Rep; 2013 Mar; 29(3):1080-6. PubMed ID: 23254951
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of RAGE expression inhibits colorectal cancer cell invasion and suppresses angiogenesis in vitro and in vivo.
Liang H; Zhong Y; Zhou S; Peng L
Cancer Lett; 2011 Dec; 313(1):91-8. PubMed ID: 21945853
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation.
Zhang YW; Su Y; Volpert OV; Vande Woude GF
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12718-23. PubMed ID: 14555767
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration.
Xiong S; Grijalva R; Zhang L; Nguyen NT; Pisters PW; Pollock RE; Yu D
Cancer Res; 2001 Feb; 61(4):1727-32. PubMed ID: 11245489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
